---
title: "Dyne Therapeutics (DYN.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/DYN.US/norm.md"
symbol: "DYN.US"
name: "Dyne Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/DYN.US.md"
datetime: "2026-05-20T18:44:47.469Z"
locales:
  - [en](https://longbridge.com/en/quote/DYN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DYN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DYN.US/norm.md)
---

# Dyne Therapeutics (DYN.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.7323 | -0.7584 | -0.7619 | -0.9735 | -1.05 |
| ROE | -52.63% | -53.83% | -68.42% | -71.50% | -71.06% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -120.85M | -111.95M | -108.04M | -110.86M | -115.36M |
| 营业利润 | -125.28M | -116.13M | -113.89M | -115.79M | -122.37M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 1.08B | 1.19B | 867.06M | 728.99M | 721.07M |
| 权益乘数 | 1.25 | 1.22 | 1.25 | 1.28 | 1.08 |
| 每股净资产 | 5.24 | 5.89 | 4.85 | 5.00 | 5.89 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 972.16M | 1.11B | 791.89M | 683.92M | 677.49M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 43.33M | 44.77M | 45.79M | 28.53M | 29.63M |
| 净债务 | -803.48M | -941.36M | -671.42M | -562.85M | -654.16M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -144.92M | -111.83M | -90.78M | -94.70M | -105.89M |
| 投资现金流 | -2.39M | 982000.00 | -37.97M | 6.77M | 1.46M |
| 融资现金流 | 7.06M | 430.96M | 217.33M | 100.77M | 141.24M |
| 自由现金流 | -97.15M | -72.15M | -60.77M | -55.72M | -67.58M |
| 现金流充裕率 | -18115.25% | -23105.79% | -473.18% | -157838.33% | -10794.39% |
| 举债与偿债 | 6.79M | 49.45M | 0.0000 | 98.80M | - |
| 资本支出 | -221000.00 | -484000.00 | -19.18M | -60000.00 | -981000.00 |